STOCK TITAN

PROCEPT BioRobotics (PRCT) grants RSUs and options to Chief Strategy & Marketing Officer

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PROCEPT BioRobotics Corp reported that Chief Strat/Marketing Officer Pooja Sharma received equity awards on August 13, 2026. She was granted 23,622 restricted stock units, each representing one share of common stock, and a stock option for 32,681 shares at an exercise price of $21.95 per share, expiring August 12, 2036.

The RSUs vest 25% on August 13, 2027, with the remainder vesting quarterly over 36 months, subject to continued service. The option vests in equal monthly installments over four years starting August 13, 2026. Both grants are intended to represent 50% of the value of Sharma’s expected 2027 grant, made in lieu of that portion. Following these awards, she directly holds 111,181 shares of common stock.

Positive

  • None.

Negative

  • None.
Insider Sharma Pooja
Role Chief Strat/Marketing Officer
Type Security Shares Price Value
Grant/Award Stock Option (Right to Buy) F2 32,681 $0.00 $0.00
Grant/Award Common Stock F1 23,622 $0.00 $0.00
Holdings After Transaction: Stock Option (Right to Buy) — 32,681 shares (Direct); Common Stock — 111,181 shares (Direct)
Footnotes (2)
  1. F1. These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on August 13, 2027, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. The grant is intended to be 50% of the value of the Reporting Person's expected 2027 grant, and made in lieu of such portion of the expected 2027 grant.
  2. F2. 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of August 13, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. The grant is intended to be 50% of the value of the Reporting Person's expected 2027 grant, and made in lieu of such portion of the expected 2027 grant.
RSUs granted 23,622 shares Restricted stock units granted to Pooja Sharma on August 13, 2026
Stock options granted 32,681 shares Stock Option (Right to Buy) granted to Pooja Sharma on August 13, 2026
Option exercise price $21.95 per share Exercise price for 32,681-share stock option grant
Option expiration date August 12, 2036 Expiration of stock option granted on August 13, 2026
Common shares held after transaction 111,181 shares Direct common stock holdings of Pooja Sharma following grants
RSU initial vesting 25% on August 13, 2027 First vesting tranche of 23,622 RSUs
restricted stock units (RSUs) financial
"These securities are restricted stock units (RSUs). Each RSU represents a contingent right"
Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.
vesting commencement date financial
"1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date"
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"

FAQ

What equity awards did PROCEPT BioRobotics (PRCT) grant to Pooja Sharma?

PROCEPT BioRobotics granted 23,622 RSUs and a stock option for 32,681 shares at $21.95 per share to Chief Strat/Marketing Officer Pooja Sharma on August 13, 2026.

How do the new RSUs for PROCEPT BioRobotics (PRCT) executive Pooja Sharma vest?

The 23,622 RSUs vest 25% on August 13, 2027, with the remaining RSUs vesting in equal quarterly installments over 36 months, contingent on continued service with PROCEPT BioRobotics.

What are the terms of Pooja Sharma’s new stock option at PROCEPT BioRobotics (PRCT)?

Pooja Sharma received a stock option for 32,681 shares of common stock at an exercise price of $21.95 per share, vesting monthly over four years from August 13, 2026, and expiring on August 12, 2036.

How do these 2026 equity grants relate to Pooja Sharma’s expected 2027 grant at PRCT?

Both the RSU and stock option awards are intended to represent 50% of the value of Pooja Sharma’s expected 2027 grant and are made in lieu of that portion of the 2027 award.

How many PROCEPT BioRobotics (PRCT) common shares does Pooja Sharma hold after these grants?

After the August 13, 2026 transactions, Pooja Sharma directly holds 111,181 shares of PROCEPT BioRobotics common stock, in addition to the newly granted option for 32,681 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Sharma Pooja

(Last)(First)(Middle)
150 BAYTECH DR

(Street)
SAN JOSE CALIFORNIA 95134

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PROCEPT BioRobotics Corp [ PRCT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Strat/Marketing Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/13/2026A23,622(1)A$0111,181D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$21.9508/13/2026A32,681 (2)08/12/2036Common Stock32,681$032,681D
Explanation of Responses:
1. These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on August 13, 2027, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. The grant is intended to be 50% of the value of the Reporting Person's expected 2027 grant, and made in lieu of such portion of the expected 2027 grant.
2. 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of August 13, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. The grant is intended to be 50% of the value of the Reporting Person's expected 2027 grant, and made in lieu of such portion of the expected 2027 grant.
Remarks:
/s/ Jonathan Stone, Attorney-in-Fact for Pooja Sharma08/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)